Liebscher Ines, Ackley Brian, Araç Demet, Ariestanti Donna M, Aust Gabriela, Bae Byoung-il, Bista Bigyan R, Bridges James P, Duman Joseph G, Engel Felix B, Giera Stefanie, Goffinet André M, Hall Randy A, Hamann Jörg, Hartmann Nicole, Lin Hsi-Hsien, Liu Mingyao, Luo Rong, Mogha Amit, Monk Kelly R, Peeters Miriam C, Prömel Simone, Ressl Susanne, Schiöth Helgi B, Sigoillot Séverine M, Song Helen, Talbot William S, Tall Gregory G, White James P, Wolfrum Uwe, Xu Lei, Piao Xianhua
Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Leipzig, Germany.
Ann N Y Acad Sci. 2014 Dec;1333(1):43-64. doi: 10.1111/nyas.12580. Epub 2014 Nov 25.
The class of adhesion G protein-coupled receptors (aGPCRs), with 33 human homologs, is the second largest family of GPCRs. In addition to a seven-transmembrane α-helix-a structural feature of all GPCRs-the class of aGPCRs is characterized by the presence of a large N-terminal extracellular region. In addition, all aGPCRs but one (GPR123) contain a GPCR autoproteolysis-inducing (GAIN) domain that mediates autoproteolytic cleavage at the GPCR autoproteolysis site motif to generate N- and a C-terminal fragments (NTF and CTF, respectively) during protein maturation. Subsequently, the NTF and CTF are associated noncovalently as a heterodimer at the plasma membrane. While the biological function of the GAIN domain-mediated autocleavage is not fully understood, mounting evidence suggests that the NTF and CTF possess distinct biological activities in addition to their function as a receptor unit. We discuss recent advances in understanding the biological functions, signaling mechanisms, and disease associations of the aGPCRs.
粘附性G蛋白偶联受体(aGPCRs)家族有33个人类同源物,是G蛋白偶联受体中第二大的家族。除了所有G蛋白偶联受体共有的七次跨膜α螺旋结构特征外,aGPCRs家族的特点还在于其存在一个大的N端胞外区域。此外,除了一个成员(GPR123)外,所有aGPCRs都含有一个GPCR自催化诱导(GAIN)结构域,该结构域在GPCR自催化位点基序处介导自催化切割,在蛋白质成熟过程中产生N端和C端片段(分别为NTF和CTF)。随后,NTF和CTF在质膜上以异二聚体形式非共价结合。虽然GAIN结构域介导的自切割的生物学功能尚未完全了解,但越来越多的证据表明,NTF和CTF除了作为受体单元发挥功能外,还具有独特的生物学活性。我们讨论了在理解aGPCRs的生物学功能、信号传导机制和疾病关联方面的最新进展。